|
|
| MRD / Regn No. |
: SG004676 |
Date |
: 16/07/2026 |
| Patient Name |
: Bhola Nath Mondal |
Age & Gender |
: 57 Yrs. / Male |
| Contact No. |
: 9661214829 |
UHID |
: |
| Ht / Wt / BMI |
: 171 / 72 / 24.62 |
BP S / BP D |
: 173 / 83 |
| Allergies |
: NKA |
Referred By |
: |
| |
|
| Problem
List |
: |
LEFT NEPHRECTOMY (16/Jul/2022) | TYPE 2 DIABETES (16/Jul/2006) | HYPERTENSION (16/Jul/2026) | CKD 3B (16/Jul/2026) | |
| Salient Investigations |
: |
CREATININE: 1.6 | EGFR EGLOMERULAR FILTRATION RATE: 47.63 mL/min/1.73m2 | HB HEMOGLOBIN: 10.5 g/dL | HBA1C GLYCOSYLATED HEMOGLOBIN: 10.9 % | LDL LOW DENSITY LIPOPROTEIN: 85 mg/dL | TSH THYROID STIMULATING HORMONE: 3.23 mIU/L |
|
|
S# |
Generic (Trade) Name |
Route |
Dosage |
Usage |
Duration |
|
1 |
INJECTION DEGLUDEC (INJ U100)
TRESIBA
Medicine For DIABETES |
SQ |
0-0-20 |
AT BEDTIME
|
TILL NEXT VISIT |
| MAY CAUSE HYPOGLYCEMIA | |
|
2 |
ANTIHYPERGLYCEMIC SEMAGLUTIDE 5.0 MG
OZEMPIC 0.5 MG |
SC |
ONCE A WEEK |
AFTER BREAKFAST
|
TILL NEXT VISIT |
|
|
3 |
DAPAGLIFLOZIN 10 MG
OXRA 10 MG |
PO |
1-0-0 |
BEFORE BREAKFAST
|
TILL NEXT VISIT |
|
|
4 |
REPAGLINIDE
EUREPA 2 MG |
PO |
0-1-0 |
BEFORE LUNCH
|
TILL NEXT VISIT |
|
|
5 |
AMLODIPINE 5 MG + TELMISARTAN 40 MG
TAZLOC AM |
PO |
1-0-1 |
BEFORE BREAKFAST AND DINNER
|
TILL NEXT VISIT |
|
|
6 |
ATORVASTATIN 20 MG
TONACT 20 MG |
|
0-0-1 |
BEFORE DINNER
|
TILL NEXT VISIT |
|
|
| |
|
|
|
| Refill :
0 / Substitution: |
|
|
| Education |
: |
| Next Visit |
: 16/Jan/2027 |
| Tests Suggested For Next Visit |
: SMBG,HBA1C-HPLC METHOD,RETINA CHECK UP,CREATININE,ECG (ALL LEADS) |
| |
|
| |
|
Dr. Samit Ghosal
MD (GM), Diploma in Diabetes Cardiff University, MSc (Diabetes Care) Glamorgan University, Diploma in Endocrinology Glamorgan University (USW), SCOPE certification in obesity management
West Bengal /
54020
This is a Computer generated Prescription |
Powered By:  |